
Invicta Diagnostic
NSE SME₹2,72,000 / Individual : 3200 Shares
IPO Live Subscription Details
| Category | Subscription (Times) |
|---|---|
| Date | 03 Dec 2025, 05:57 PM |
| QIBs | 3.51 times |
| NII | 7.27 times |
| Total | 4.34 times |
Invicta Diagnostic IPO Details
The Invicta Diagnostic IPO price band is set between ₹80-85 per equity share, with a face value of ₹10 per share. The issue is managed by Bigshare Services Pvt Ltd, and the equity shares are proposed to be listed on the NSE SME.
The IPO date for subscription opens on 1 Dec, 2025 and closes on 3 Dec, 2025. Investors can check the allotment status on 4 Dec, 2025, while the listing date is tentatively scheduled for 8 Dec, 2025.
The total issue size is 33,08,800 shares, aggregating up to ₹28.12 crore. Stay tuned for the latest Invicta Diagnostic IPO review and GMP updates.
Invicta Diagnostic IPO Review, Rating & Analysis
Invicta Diagnostic IPO Review
NO REVIEWInvicta Diagnostic IPO Rating
Invicta Diagnostic IPO Highlights
IPO Date
Dec 1, 2025 - Dec 3, 2025
Listing Date
8 Dec, 2025
Face Value
₹10 Per Equity Share
Price Band
₹80-85 per equity share
Lot Size
-
Fresh Issue
Shares
Offer for Sale
-
Listing At
NSE SME
Invicta Diagnostic IPO Lot Size
The minimum market lot for Invicta Diagnostic IPO is 3200 shares with an application amount of ₹2,72,000. Retail investors can apply for up to 0 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 3200 | ₹2,72,000 |
| Retail (Max) | 0 | 0 | ₹0 |
| S-HNI (Min) | 1 | 3200 | ₹2,72,000 |
| S-HNI (Max) | 3 | 9600 | ₹8,16,000 |
| B-HNI (Min) | 4 | 12800 | ₹10,88,000 |
Invicta Diagnostic IPO Timeline
Issue Price
₹80-85 per equity shareFace Value
₹10 Per Equity ShareListing at Group
NSE SMERegistrar
Bigshare Services Pvt LtdLead Manager
Socradamus Capital Pvt LtdIssue Size
33,08,800 shares(aggregating up to ₹28.12 crore)Invicta Diagnostic IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 30-Sep-25 | 34.90 | 17.08 | 4.08 | 23.68 | 14.42 | 3.72 |
| 31-Mar-25 | 21.22 | 30.18 | 4.93 | 13.60 | 5.18 | 3.54 |
| 31-Mar-24 | 15.89 | 15.90 | 3.81 | 8.67 | 8.54 | 3.81 |
In Cr.
Invicta Diagnostic IPO Reservation Details
| Investor Category | Shares Offered | % Shares |
|---|---|---|
| Anchor Investor Shares Offered | 798400 | 24.13% |
| Market Maker Shares Offered | 166400 | 5.03% |
| QIB Shares Offered | 534400 | 16.15% |
| NII (HNI) Shares Offered | 542400 | 16.39% |
| bNII > ₹10L | 361600 | 9.39% |
| sNII < ₹10L | 180800 | 4.85% |
| Individual Shares Offered | 1267200 | 38.3% |
| Total Shares Offered | 3308800 | 100% |
Invicta Diagnostic IPO Documents
Invicta Diagnostic IPO Valuations
EPS Pre IPO
₹5.86/-EPS Post IPO
₹6.50/-PE Pre IPO
14.51PE Post IPO
13.08ROE
44.28%ROCE
42.00%Debt Equity
0.26RoNW
36.25%PAT Margin
16.38%Price to Book Value
5.26Promoters & Share Holding
Promoter(s) Name
- Dr. Ketan Jayantilal Jain
- Dr. Sanket Vinod Jain
- Rohit Prakash Srivastava
- Badal Kailash Naredi
- Jayesh Prakash Jain
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| % | % |
About Company
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology and radiology testing comprising imaging, radiology, pathology, and teleradiology services under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra.
Invicta Diagnostics Limited, trading as PC Diagnostics, is a Mumbai-based diagnostic services company specializing in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:
A flagship hub offering full-spectrum pathology and advanced radiology (CT, MRI) at Thane West
Three other centres - Bhayandar, Byculla, Marol - offering specialized diagnostic services
Basic imaging, including X-ray and ultrasound, and sample collection were the focus of spokes at Lower Parel, Sewri, Mazgaon, and Kalwa.
It offers approximately 60 routine and 487 specialized pathology tests and around 96 basic and 130 advanced radiology investigations.
Invicta Diagnostics provides a comprehensive suite of diagnostic services that includes:
Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels
Specialized Tests: Molecular diagnostics, immunoassays, infectious disease markers including dengue, COVID-19, cancer markers, and genetic panels.
Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres. The company has a network of 5 laboratory doctors, 20 radiologists, and 127 well-trained technical staff as of May 31st, 2025. The company has 105 permanent employees as of May 31, 2025.
Invicta Diagnostic IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 5,34,400 | 5,42,400
3,61,600
1,80,800
| 12,67,200 | 23,44,000 |
Day 101-12-25 05:00 PM | 1.00 x | 0.68
0.79 x
0.45 x
| 0.28 x | 0.54 x |
Day 202-12-25 05:00 PM | 1.55 x | 1.04
1.27 x
0.58 x
| 0.79 x | 1.02 x |
Day 303-12-25 05:00 PM | 3.51 x | 7.27
7.76 x
6.27 x
| 3.44 x | 4.34 x |
Retail:3.44x
BHNI:2.52x
SHNI:5.74x
Invicta Diagnostic IPO - Issue Objectives & Utilisation of proceeds
| Objectives | Amount |
|---|---|
| Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra | - |
| General Corporate purposes | - |
Company Contact Details
Invicta Diagnostic
1 GF, Plot 217, Ambavat Bhavan, N.M Joshi Marg, Delisle Road, Mumbai, Maharashtra, 400013Registrar Contact Details
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Frequently Asked Questions about Invicta Diagnostic IPO
When will Invicta Diagnostic IPO open for subscription?
The Invicta Diagnostic IPO opens on 1 Dec, 2025 and closes on 3 Dec, 2025.
What is the investors portion for Invicta Diagnostic IPO?
The investors' portion for QIB is 3.51 x, NII is 7.76 x, and Retail is 3.44 x.
How to apply for Invicta Diagnostic IPO?
You can apply for Invicta Diagnostic IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Invicta Diagnostic IPO?
The issue size of Invicta Diagnostic IPO is approx ₹33,08,800 shares(aggregating up to ₹28.12 crore) crores.
What is the price band of Invicta Diagnostic IPO?
The price band for Invicta Diagnostic IPO is ₹80 to ₹85 per equity share.
What is the lot size of Invicta Diagnostic IPO?
The minimum bid (lot size) for Invicta Diagnostic IPO is 1600 shares with an investment of approx ₹2,72,000 .
What is the allotment date of Invicta Diagnostic IPO?
The allotment date for Invicta Diagnostic IPO is 4 Dec, 2025.
What is the listing date of Invicta Diagnostic IPO?
The listing date for Invicta Diagnostic IPO is expected to be 8 Dec, 2025.
What is the GMP of Invicta Diagnostic IPO?
The latest Grey Market Premium (GMP) for Invicta Diagnostic IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.
